GlassScriptPhysician profile
Salvin Jacob
NPI 1134656697
$6,525.38
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2021: $2,543 · 2022: $3,861.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,707.47 | 2021-2022 | |
| Abbott Laboratories | $1,293.93 | 2021-2022 | |
| Medtronic, INC. | $937.27 | 2021-2022 | |
| Foundation Fusion Solutions, LLC | $713.00 | 2021-2022 | |
| Nevro Corp. | $216.50 | 2021 | |
| Painteq LLC | $163.94 | 2021 | |
| Relievant Medsystems, INC. | $149.68 | 2021 | |
| Merck Sharp & Dohme LLC | $120.67 | 2019 | |
| Abbvie INC. | $102.91 | 2021 | |
| Allergan, INC. | $102.07 | 2021 | |
| Avanos Medical | $17.94 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salvin Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.